The common denominator in MO and SO diseases is that most of these patients have a defect in the leptin-melanocortin pathway that leads to early-onset obesity and hyperphagia (defined by impaired satiety and satiation leading to food-seeking behaviour).4 The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.